| |
National Eye Institute (NEI)40 Protocols (35 Active Accrual of new subjects, 5 Follow-up of previously enrolled subjects)
-
 09-EI-0008:
Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration
-
08-EI-0175:
Pilot Study of the Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema
-
08-EI-0169:
Evaluation and Treatment Protocol for Potential Research Participants with Ocular Diseases
-
08-EI-0147:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia without Neovascularization (MACTEL 2)
-
08-EI-0146:
Pilot Study of Intravitreal Injection of Ranibizumab for Macular Telangiectasia with Neovascularization (MACTEL 1)
-
08-EI-0135:
Pilot Validation Study of Computer Administration of Vision Targeted Quality of Life Instruments
-
08-EI-0129:
Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau Syndrome
-
08-EI-0103:
High Speed Indocyanine Green Angiography Findings in Induction / PRN Regimen of Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration
-
08-EI-0102:
Screening Study for the Evaluation and Diagnosis of Potential Research Participants
-
08-EI-0099:
Epigenetics, Molecular Genetics, and Biomarkers of Degenerative and Inflammatory Ocular Diseases
-
08-EI-0061:
Pilot Study for the Detection of Neutralizing Antibodies in Patients treated with Bevacizumab (Avastin™ (Trademark)) or Ranibizumab (Lucentis™ (Trademark))
-
08-EI-0043:
Age-Related Eye Disease Study (AREDS) Follow-Up
-
08-EI-0031:
Visual Motor Coordination
-
07-EI-0145:
Ocular Impact of X Chromosome Karyotype and Sex Hormones in Turner Syndrome and Premature Ovarian Failure
-
06-EI-0252:
A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism
-
06-EI-0236:
National Ophthalmic Genotyping Network Stage 1 - Creation of DNA Repository for Inherited Ophthalmic Diseases
-
06-EI-0230:
Family Studies of Uveal Coloboma
-
06-EI-0111:
Treatment of Choroidal Subretinal Neovascularization with Agents Directed Against the Immune Response
-
06-EI-0068:
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
-
06-EI-0059:
Clinical and Molecular Studies in Families with Glaucoma and Related Diseases
-
06-EI-0058:
Clinical and Molecular Studies in Families with Myopia and Related Diseases
-
06-EI-0050:
Multicenter Uveitis Steroid Treatment (MUST) Trial Protocol
-
05-EI-0143:
Molecular Genetics of Retinal Degenerations
-
05-EI-0104:
Familial Exudative Vitreoretinopathy Clinical and Molecular Studies
-
05-EI-0096:
Natural History and Genetic Studies of Usher Syndrome
-
04-EI-0008:
Clinical and Molecular Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases
-
03-EI-0255:
Pilot Study on the Effect of Vitamin A Supplementation on Cone Function in Retinitis Pigmentosa
-
03-EI-0155:
Evaluation of Single Nucleotide Polymorphism (SNP) in Patients with and Subjects without Age-Related Macular Degeneration (AMD)
-
03-EI-0123:
Clinical and Molecular Studies in Families with Congenital or Hereditary Cataracts
-
03-EI-0122:
Evaluation of Immune Responses to Different Antigens in Non Infectious Ocular Inflammatory Diseases
-
03-EI-0033:
X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies
-
01-EI-0046:
Evaluation and Treatment of Corneal and External Diseases and Anterior Segment Disorders
-
00-EI-0135:
Study of Association of Serum Factors with Diabetic Retinopathy
-
92-EI-0113:
Immunopathology and Molecular Pathology of Ocular Diseases in Humans
-
86-EI-0062:
Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis
-
 07-EI-0213:
LI/National Eye Institute Repository
-
07-EI-0025:
The Age-Related Eye Disease Study 2 (AREDS2): A Multi-Center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration
-
06-EI-0116:
A Phase II Study of OT-551 Antioxidant Eye Drop in Participants with Bilateral Geographic Atrophy Associated with Age-Related Macular Degeneration
-
06-EI-0046:
Treatment of Non-Infectious Intermediate and Posterior Uveitis Associated Macular Edema with Humanized Anti-CD11a Antibody Therapy
-
05-EI-0002:
A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease (GVHD1)
Search The Studies | Help | Questions
|
Clinical Center Home | NIH Home
 National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/13/2009
|
|